The British medtech company Brainomix has announced that it has closed a series B funding round with a total investment of approximately £16 million.
The previous investors Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund (OUIF), who are participating again in this round, have been joined by Tencent Holdings.
WHY IT MATTERS
Brainomix recently took the ...
